We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$730M
AUM Growth
+$169M
Cap. Flow
+$111M
Cap. Flow %
15.2%
Top 10 Hldgs %
18.73%
Holding
130
New
27
Increased
88
Reduced
13
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 19.94%
2 Technology 17.32%
3 Financials 16.14%
4 Healthcare 11.97%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFOR
1
Everforth Inc
EFOR
$960M
$15.9M 2.17%
359,436
+35,905
+11% +$1.43M
IWM icon
2
iShares Russell 2000 ETF
IWM
$79.1B
$15.7M 2.15%
116,231
+73,633
+173% +$9.41M
MSCC
3
DELISTED
Microsemi Corp
MSCC
$14.9M 2.04%
276,562
+36,309
+15% +$1.77M
CUBI icon
4
Customers Bancorp
CUBI
$2.66B
$13.8M 1.89%
385,731
+18,186
+5% +$537K
NBHC icon
5
National Bank Holdings
NBHC
$1.9B
$13.7M 1.88%
429,361
+46,963
+12% +$1.26M
MMSI icon
6
Merit Medical Systems
MMSI
$4.82B
$13M 1.78%
489,831
+46,279
+10% +$1.12M
PRXL
7
DELISTED
Parexel International Corp
PRXL
$12.8M 1.75%
194,324
+30,082
+18% +$1.89M
EEFT icon
8
Euronet Worldwide
EEFT
$3.19B
$12.5M 1.71%
172,732
+26,400
+18% +$2.04M
MATW icon
9
Matthews International
MATW
$887M
$12.3M 1.68%
159,796
+25,573
+19% +$1.72M
QTS
10
DELISTED
QTS REALTY TRUST, INC.
QTS
$12.3M 1.68%
247,144
+44,987
+22% +$2.17M
EVHC
11
DELISTED
Envision Healthcare Holdings Inc
EVHC
$11.7M 1.6%
+184,286
New +$12M
EFII
12
DELISTED
Electronics for Imaging
EFII
$11.4M 1.56%
260,208
+41,456
+19% +$1.82M
PVTB
13
DELISTED
PrivateBancorp Inc
PVTB
$11.2M 1.53%
205,817
+35,034
+21% +$1.69M
DGI
14
DELISTED
DigitalGlobe Inc.
DGI
$11.1M 1.52%
386,787
+36,623
+10% +$1.06M
CRI icon
15
Carter's
CRI
$1.43B
$11M 1.51%
127,211
+16,779
+15% +$1.5M
DY icon
16
Dycom Industries
DY
$11.2B
$11M 1.5%
136,836
+25,081
+22% +$2.03M
ALE
17
DELISTED
Allete
ALE
$11M 1.5%
170,904
+27,220
+19% +$1.66M
PLKI
18
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$11M 1.5%
181,303
+27,515
+18% +$1.58M
BDC icon
19
Belden
BDC
$3.97B
$10.6M 1.45%
141,419
+21,026
+17% +$1.5M
IWN icon
20
iShares Russell 2000 Value ETF
IWN
$14.3B
$10.5M 1.43%
87,869
+44,880
+104% +$4.96M
ROG icon
21
Rogers Corp
ROG
$2.09B
$10.4M 1.43%
135,880
+14,676
+12% +$994K
AEIS icon
22
Advanced Energy
AEIS
$10.1B
$10.2M 1.4%
187,165
+32,190
+21% +$1.65M
ITRI icon
23
Itron
ITRI
$4.48B
$9.98M 1.37%
158,825
+27,260
+21% +$1.64M
FLWS icon
24
1-800-Flowers.com
FLWS
$252M
$9.95M 1.36%
929,984
+50,337
+6% +$507K
HASI icon
25
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$9.51M 1.3%
500,911
+10,753
+2% +$221K

Similar funds

Aristotle Capital Boston's Q4 2016 Portfolio in Review

As of Q4 2016, Aristotle Capital Boston held 130 positions worth $730M, up 30% from $561M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $111M of net new capital in Q4 2016, opening 27 new positions and adding to 88 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Wabash National, an estimated $1.35M trimmed.

  • Aristotle Capital Boston's largest Q4 2016 buy was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
  • Aristotle Capital Boston added most to iShares Russell 2000 ETF in Q4 2016, an estimated $9.41M increase.
  • Aristotle Capital Boston's biggest Q4 2016 reduction was Wabash National, cutting an estimated $1.35M.
  • Aristotle Capital Boston fully exited Amsurg Corp in Q4 2016, selling an estimated $10.2M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $730M portfolio in Q4 2016.
  • Aristotle Capital Boston opened 27 new positions and closed 2 in Q4 2016.
  • Aristotle Capital Boston's portfolio value rose 30% quarter-over-quarter to $730M.

Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.